![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. 3-methylxanthine, Methyl-(13)c-labeled
2. 3-methylxanthine, Monopotassium Salt
3. 3-methylxanthine, Monosodium Salt
1. 1076-22-8
2. 2,6-dihydroxy-3-methylpurine
3. 3-methyl-1h-purine-2,6(3h,7h)-dione
4. 3-methyl-7h-purine-2,6-dione
5. 3 Mx
6. Xanthine, 3-methyl-
7. 3-methyl Xanthine
8. 1h-purine-2,6-dione, 3,7-dihydro-3-methyl-
9. 3,7-dihydro-3-methyl-1h-purine-2,6-dione
10. 3-methyl-7h-xanthine
11. 3-methyl-2,3,6,7-tetrahydro-1h-purine-2,6-dione
12. Mfcd00005580
13. Chembl619
14. Ws6x982oec
15. Theophylline Related Compound B
16. 3-methyl-3,7-dihydro-1h-purine-2,6-dione
17. Chebi:62207
18. Nsc-515466
19. 3-methyl-3,9-dihydro-purine-2,6-dione
20. 3-methyl-3,9-dihydro-1h-purine-2,6-dione
21. 3-methyl-3,7-dihydro-1h-purine-2,6-dione (3-methylxanthine)
22. Ccris 5817
23. 3-methyl-3,7(9)-dihydro-purine-2,6-dione
24. Einecs 214-058-1
25. Unii-ws6x982oec
26. Nsc 515466
27. 3-methyl-xanthine
28. 3-methyl-9h-xanthine
29. Spectrum_001898
30. 3-methyl-1h-purine-2,6(3h,9h)-dione
31. Specplus_000737
32. Linagliptin Intermediates
33. Spectrum2_000502
34. Spectrum3_001652
35. Spectrum4_001571
36. Spectrum5_001544
37. 3-methylxanthine, 98%
38. N(1)-demethyltheophylline
39. 2-oxo-3-methylhypoxanthine
40. Oprea1_233226
41. Oprea1_288071
42. Bspbio_003403
43. Kbiogr_002122
44. Kbioss_002428
45. Bidd:gt0266
46. Divk1c_006833
47. Schembl237146
48. Spectrum1504182
49. Spbio_000423
50. Schembl8663339
51. 3-methyl-3h-purine-2,6-diol
52. 3-methyl-9h-purine-2,6-dione
53. Chebi:62208
54. Kbio1_001777
55. Kbio2_002422
56. Kbio2_004990
57. Kbio2_007558
58. Kbio3_002623
59. Dtxsid90148107
60. 1-methylxanthine (1-mx)
61. Bcp18161
62. Zinc4685854
63. Bbl012772
64. Bdbm50001515
65. Ccg-39565
66. Geo-01981
67. Nsc515466
68. S6186
69. Stk776266
70. Wln: T56 Bm Dn Fnvmvj F1
71. Akos002272340
72. Akos004120009
73. Akos006221835
74. Zinc100459831
75. Cs-w020049
76. Ds-1280
77. 3-methyl-3,7-dihydropurine-2,6-dione
78. 1h-purine-2, 3,7-dihydro-3-methyl-
79. Ncgc00095330-01
80. Ncgc00095330-02
81. Ncgc00178088-01
82. 3-methyl-3,7-dihydro-purine-2,6-dione
83. Hy-50723
84. Sy031706
85. Db-040769
86. 3,9-dihydro-3-methyl-1h-purine-2,6-dione
87. Am20080030
88. Ft-0616197
89. M2073
90. Theophylline Impurity B [ep Impurity]
91. Pentoxifylline Impurity B [ep Impurity]
92. 3-methyl-3,9-dihydro-1h-purine-2,6-dione #
93. 3-methyl-3,9-dihydro-2h,6h-purine-2,6-dione
94. 3-methyl-7h-purine-2,6-dione;3-methylxanthine
95. Theophylline Related Compound B [usp-rs]
96. 076m228
97. A801730
98. J-505016
99. W-108741
100. Q27888118
101. Theophylline Related Compound B [usp Impurity]
102. Theophylline Monohydrate Impurity B [ep Impurity]
103. Z1741977122
104. 3-methyl-3,9-dihydro-purine-2,6-dione(3-methyl Xanthine)
105. Theophylline Related Compound B, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 166.14 g/mol |
---|---|
Molecular Formula | C6H6N4O2 |
XLogP3 | -0.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 0 |
Exact Mass | 166.04907545 g/mol |
Monoisotopic Mass | 166.04907545 g/mol |
Topological Polar Surface Area | 78.1 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 242 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
3-Methylxanthine is a known human metabolite of theobromine and theophylline.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560